The Controversy Regarding Margin Width in Breast Cancer: Enough is Enough Kelly K. HuntBenjamin D. SmithElizabeth A. Mittendorf Breast Oncology 29 January 2014 Pages: 701 - 703
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer Meena S. MoranStuart J. SchnittMonica Morrow Breast Oncology – Special Article 10 February 2014 Pages: 704 - 716
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis Nehmat HoussamiPetra MacaskillMonica Morrow Breast Oncology 29 January 2014 Pages: 717 - 730
Follow-Up After Curative Cancer Surgery: Understanding Costs and Benefits Bridget N. Fahy Healthcare Policy and Outcomes 27 December 2013 Pages: 731 - 732
Intensity of Follow-Up After Breast Cancer Surgery: Low Versus High? Julie A. MargenthalerFrank E. JohnsonAmy E. Cyr Breast Oncology 18 September 2013 Pages: 733 - 737
Follow-up After Curative Resection of Colorectal Cancer Bridget N. Fahy Colorectal Cancer 22 November 2013 Pages: 738 - 746
Intensity of Follow-up after Pancreatic Cancer Resection Jason A. CastellanosNipun B. Merchant Pancreatic Tumors 04 October 2013 Pages: 747 - 751
Intensity of Follow-Up After Melanoma Surgery Christopher P. ScallySandra L. Wong Melanomas 10 October 2013 Pages: 752 - 757
Treatment Options and Surveillance Strategies After Therapy for Hepatocellular Carcinoma Ioannis HatzarasDanielle A. BischofTimothy M. Pawlik Hepatobiliary Tumors 05 September 2013 Pages: 758 - 766
A Cost-Utility Analysis for Prophylactic Central Neck Dissection in Clinically Nodal-Negative Papillary Thyroid Carcinoma Carlos K. H. WongBrian Hung-Hin Lang Endocrine Tumors 26 November 2013 Pages: 767 - 777
Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma Eun-Seok ChoiHan-Soo KimIlkyu Han Bone and Soft Tissue Sarcomas 04 December 2013 Pages: 778 - 785
Breast-Conserving Surgery With or Without Radiotherapy in Older Breast Patients With Early Stage Breast Cancer: A Systematic Review and Meta-analysis Willemien van de WaterEsther BastiaannetGerrit-Jan Liefers Breast Oncology 23 November 2013 Pages: 786 - 794
Reducing Persistent Postoperative Pain and Disability 1 Year After Breast Cancer Surgery: A Randomized, Controlled Trial Comparing Thoracic Paravertebral Block to Local Anesthetic Infiltration Michelle ChiuGregory L. BrysonHoward J. Nathan Breast Oncology Open access 29 October 2013 Pages: 795 - 801
Quilting Prevents Seroma Formation Following Breast Cancer Surgery: Closing the Dead Space by Quilting Prevents Seroma Following Axillary Lymph Node Dissection and Mastectomy Britt ten WoldeFrits J. H. van den WildenbergLuc J. A. Strobbe Breast Oncology 12 November 2013 Pages: 802 - 807
Harmonic Scalpel Versus Electrocautery Dissection in Modified Radical Mastectomy: A Randomized Controlled Trial Salma KhanShaista KhanGhulam Murtaza Breast Oncology 14 November 2013 Pages: 808 - 814
Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease Kenneth CardonaDino DonataccioMichael I. D’Angelica Colorectal Cancer 18 November 2013 Pages: 815 - 821
An MRI-based Assessment of Standard and Extralevator Abdominoperineal Excision Specimens: Time for a Patient Tailored Approach? Peter HowNicholas P. WestG. Brown Colorectal Cancer 23 November 2013 Pages: 822 - 828
Attaining Surgical Competency and Its Implications in Surgical Clinical Trial Design: A Systematic Review of the Learning Curve in Laparoscopic and Robot-Assisted Laparoscopic Colorectal Cancer Surgery Jenifer BarrieDavid G. JayneSue H. Pavitt Colorectal Cancer 12 November 2013 Pages: 829 - 840
Suprapubic Single-Incision Laparoscopic Left Hemicolectomy: An Alternative Non-Visible Scar Giovanni Dapri Original Article – Colorectal Cancer 24 December 2013 Pages: 841 - 842
Risk of Thyroid Cancer in Patients with Thyroiditis: A Population-Based Cohort Study Chien-Liang LiuShih-Ping ChengYuen-Liang Lai Endocrine Tumors 08 November 2013 Pages: 843 - 849
A Systematic Review and Meta-analysis Comparing Surgically-Related Complications between Robotic-Assisted Thyroidectomy and Conventional Open Thyroidectomy Brian Hung-Hin LangCarlos K. H. WongKoon Yat Wan Endocrine Tumors 23 November 2013 Pages: 850 - 861
The Addition of Radiation to Chemotherapy does not Improve Outcome When Compared to Chemotherapy in the Treatment of Resected Pancreas Cancer: The Results of a Single-Institution Experience Ludmila Katherine MartinDai Chu LuuTanios Bekaii-Saab Gastrointestinal Oncology 18 September 2013 Pages: 862 - 867
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Konstantinos I. VotanopoulosReese W. RandleMajid Mirzazadeh Gastrointestinal Oncology 12 November 2013 Pages: 868 - 874
A Comparison of Five Competing Lymph Node Staging Schemes in a Cohort of Resectable Gastric Cancer Patients David D. SmithRebecca A. NelsonRoderich E. Schwarz Gastrointestinal Oncology 18 November 2013 Pages: 875 - 882
Morbidity Associated with Colostomy Reversal After Cytoreductive Surgery and HIPEC Erienne M. V. de CubaVictor J. VerwaalElisabeth A. te Velde Gastrointestinal Oncology 18 November 2013 Pages: 883 - 890
Prognostic Significance of Complications after Curative Surgery for Gastric Cancer Takeshi KubotaNaoki HikiToshiharu Yamaguchi Gastrointestinal Oncology 20 November 2013 Pages: 891 - 898
Anatomic Extent of Metastatic Lymph Nodes: Still Important for Gastric Cancer Prognosis Taeil SonWoo Jin HyungSung Hoon Noh Gastrointestinal Oncology 26 November 2013 Pages: 899 - 907
Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Armando SardiWilliam JimenezVadim Gushchin Gastrointestinal Oncology 26 November 2013 Pages: 908 - 914
A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy Rupert LangerKaren BeckerKatja Ott Gastrointestinal Oncology 27 November 2013 Pages: 915 - 921
Assessment of Short-Term Clinical Outcomes following Salvage Esophagectomy for the Treatment of Esophageal Malignancy: Systematic Review and Pooled Analysis Sheraz R. MarkarAlan KarthikesalingamDonald E. Low Gastrointestinal Oncology 09 November 2013 Pages: 922 - 931
T1 Squamous Cell Carcinoma of the Esophagus: Long-Term Outcomes and Prognostic Factors After Esophagectomy Toshiaki TanakaSatoru MatonoHiromasa Fujita Thoracic Oncology 15 November 2013 Pages: 932 - 938
Association of a Genetic Variant of CYP19A1 with Multicentric Development of Lung Adenocarcinomas Koei IkedaKenji ShiraishiMakoto Suzuki Thoracic Oncology 18 November 2013 Pages: 939 - 945
EGFR, BRAF and KRAS Status in Patients Undergoing Pulmonary Metastasectomy from Primary Colorectal Carcinoma: A Prospective Follow-Up Study Thomas SchweigerBalazs HegedüsKonrad Hoetzenecker Thoracic Oncology 27 November 2013 Pages: 946 - 954
HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse Elena Ioana BraicuRadoslav ChekerovKlaus Pietzner Gynecologic Oncology 12 November 2013 Pages: 955 - 962
Relation Between Age, Comorbidity, and Complications in Patients Undergoing Major Surgery for Head and Neck Cancer Thomas T. A. PetersBoukje A. C. van DijkGyorgy B. Halmos Head and Neck Oncology 19 November 2013 Pages: 963 - 970
Long-Term Outcomes and Prognostic Factors with Reductive Hepatectomy and Sequential Percutaneous Isolated Hepatic Perfusion for Multiple Bilobar Hepatocellular Carcinoma Takumi FukumotoMasahiro TominagaYonson Ku Hepatobiliary Tumors 08 November 2013 Pages: 971 - 978
Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma Kaitlyn J. KellyKaterina DukleskaYuman Fong Hepatobiliary Tumors 09 November 2013 Pages: 979 - 985
Assessing Prognostic Significance of Preoperative Alpha-Fetoprotein in Hepatitis B-Associated Hepatocellular Carcinoma: Normal is not the New Normal Sima BlankQin WangSpiros P. Hiotis Hepatobiliary Tumors 14 November 2013 Pages: 986 - 994
Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device Mustafa RaoofThomas A. AloiaSteven A. Curley Hepatobiliary Tumors 19 November 2013 Pages: 995 - 1001
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma Shuji SumieOsamu NakashimaMichio Sata Hepatobiliary Tumors 20 November 2013 Pages: 1002 - 1009
Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy? Liang-He YuNan LiShu-Qun Cheng Hepatobiliary Tumors 12 October 2013 Pages: 1010 - 1015
Prognosis of Patients with Melanoma and Microsatellitosis Undergoing Sentinel Lymph Node Biopsy Edmund K. BartlettMeera GuptaGiorgos C. Karakousis Melanomas 21 November 2013 Pages: 1016 - 1023
Src Family Kinase Inhibition as a Novel Strategy to Augment Melphalan-Based Regional Chemotherapy of Advanced Extremity Melanoma Yoshihiro TokuhisaMichael E. LidskyDouglas S. Tyler Melanomas 27 November 2013 Pages: 1024 - 1030
Tumor-Associated Macrophages Promote Oral Cancer Progression Through Activation of the Axl Signaling Pathway Chien-Hsing LeeShyun-Yeu LiuYi-Shing Shieh Translational Research and Biomarkers 26 November 2013 Pages: 1031 - 1037
Metastatic Behavior of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Association with Primary Tumor Location Nobuyuki TanakaEiji KikuchiMototsugu Oya Urologic Oncology 12 November 2013 Pages: 1038 - 1045
MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases Joana HeinzelmannAndré UnreinKerstin Junker Urologic Oncology 18 November 2013 Pages: 1046 - 1054
